1. Home
  2. NCSM vs LEXX Comparison

NCSM vs LEXX Comparison

Compare NCSM & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCSM
  • LEXX
  • Stock Information
  • Founded
  • NCSM 2006
  • LEXX 2004
  • Country
  • NCSM United States
  • LEXX Canada
  • Employees
  • NCSM N/A
  • LEXX N/A
  • Industry
  • NCSM Oilfield Services/Equipment
  • LEXX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NCSM Energy
  • LEXX Health Care
  • Exchange
  • NCSM Nasdaq
  • LEXX Nasdaq
  • Market Cap
  • NCSM 76.3M
  • LEXX 19.6M
  • IPO Year
  • NCSM 2017
  • LEXX N/A
  • Fundamental
  • Price
  • NCSM $29.80
  • LEXX $0.82
  • Analyst Decision
  • NCSM
  • LEXX Strong Buy
  • Analyst Count
  • NCSM 0
  • LEXX 1
  • Target Price
  • NCSM N/A
  • LEXX $5.00
  • AVG Volume (30 Days)
  • NCSM 7.8K
  • LEXX 89.7K
  • Earning Date
  • NCSM 07-30-2025
  • LEXX 07-14-2025
  • Dividend Yield
  • NCSM N/A
  • LEXX N/A
  • EPS Growth
  • NCSM N/A
  • LEXX N/A
  • EPS
  • NCSM 3.27
  • LEXX N/A
  • Revenue
  • NCSM $168,704,000.00
  • LEXX $615,923.00
  • Revenue This Year
  • NCSM $7.17
  • LEXX $6.04
  • Revenue Next Year
  • NCSM $5.44
  • LEXX $8.36
  • P/E Ratio
  • NCSM $9.05
  • LEXX N/A
  • Revenue Growth
  • NCSM 18.16
  • LEXX 49.85
  • 52 Week Low
  • NCSM $16.66
  • LEXX $0.81
  • 52 Week High
  • NCSM $38.95
  • LEXX $4.38
  • Technical
  • Relative Strength Index (RSI)
  • NCSM 45.63
  • LEXX 32.80
  • Support Level
  • NCSM $29.61
  • LEXX $0.86
  • Resistance Level
  • NCSM $30.82
  • LEXX $1.05
  • Average True Range (ATR)
  • NCSM 0.92
  • LEXX 0.05
  • MACD
  • NCSM -0.07
  • LEXX 0.00
  • Stochastic Oscillator
  • NCSM 27.95
  • LEXX 0.14

About NCSM NCS Multistage Holdings Inc.

NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Share on Social Networks: